ABPHARM ANALYTICAL CONSULTANCY LIMITED

🌳Matureactive

07964279 · ltd · incorporated 2012-02-24

Investment thesis

Well-run mature business — low negotiation leverage; premium likely.

Why interesting: Textbook target; clean filings, stable trading.

Why risky: No pressure on seller; any deal likely at full price.

Opportunity decay

hardening · 12-months

Already tight — no obvious softening catalysts on the horizon.

· Thesis: well-run, low negotiation leverage

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Mar 2026

Net worth

£492.0k

book net assets

Opportunity

78/100

Strong

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Research and experimental development on biotechnology

Sector: Professional, scientific & technical

Investor take

Pursue

Asset-holding vehicle with a 71-year-old founder — textbook succession opportunity.

Opportunity 78/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 71). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

2 officers (2 active, 2 linked, 2 with DOB)

Ownership & PSC

1 active PSC(s) of 1 total, 1 with control declared

Director network

Network not yet resolved

Filing history

31 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

78/100Strong

PassWatchWorth a lookStrongExceptional

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality

Active, clean filings, stable charge profile.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)

Positive net assets

Net assets £492,047

Key financials

2 years extracted from filed iXBRL accounts

Cash

—

Net Worth

£492k

Current Assets

£517k

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)

Metric	2026-03-31	2025-03-31
Total assets	£492.5k	—
Current assets	£516.7k	—
Net assets	£492.0k	—
Average employees	—	200

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filings

• 1 accounts
• 1 confirmation-statement

Last 180 days

filings

• 1 accounts
• 1 confirmation-statement

Counts from Companies House filing history.

Corporate timeline (18 events)Click to expand

2026-04-21
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2025-04-14
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2024-04-16
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2023-04-22
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2022-04-17
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2021-04-14
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2020-04-17
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2019-04-22
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2018-05-27
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2017-09-16
📍
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2017-09-16
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2016-08-15
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2016-02-26
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2015-06-14
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2015-02-27
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2012-02-24
🏢
Company incorporated
As ABPHARM ANALYTICAL CONSULTANCY LIMITED
2012-02-24
➕
BANYARD, Alan Frederick appointed
director
2012-02-24
➕
BANYARD, Petula Nancy appointed
director

Owner dependency

86/100

Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS

+Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
+Founder age: Director aged approximately 71 — succession pressure is live.
+Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
+No director turnover: Company is 14 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

79/100

Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS

primaryFounder aged 70+: Senior director is approximately 71 years old. Natural succession window is now.
secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
secondary12+ year tenure: Director in role 14 years.
supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%

Name	Shares	Voting rights	Nature of control	Notified
Mr Alan Banyard Individual · British · DOB 07/1955 · age 71	75–100%	75–100%	board control75-100% shares · 75-100% voting · board control	06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Professional services · OX postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
130R SERVICES LIMITED→ 13271145 · est 2021 · no financials extracted	—	—	—	—	5y	—	—
3 GREEN LIGHTS LTD→ 13880928 · est 2022 · no financials extracted	—	—	—	—	4y	—	—
5 RHINO CONSULTING LTD→ 13257590 · est 2021 · no financials extracted	—	—	—	—	5y	—	—
65 MANAGEMENT CONSULTANCY LTD→ 13115583 · est 2021 · no financials extracted	—	—	—	—	5y	—	—
9-2-3 JOBS LIMITED→ 10901173 · est 2017 · no financials extracted	—	—	—	—	8y	—	—
ABGERRY LTD→ 13740653 · est 2021 · no financials extracted	—	—	—	—	4y	—	—
ABINGDON ACCOUNTANCY CENTRE LIMITED→ 04391764 · est 2002 · no financials extracted	—	—	—	—	24y	—	—
ABINGDON BOOKKEEPING LTD→ 14294382 · est 2022 · no financials extracted	—	—	—	—	3y	—	—
ABINGDON88 LTD→ 16974969 · est 2026 · no financials extracted	—	—	—	—	—	—	—
ABLE GROWING CENTRE LTD→ 12192915 · est 2019 · no financials extracted	—	—	—	—	6y	—	—
ABS CONSULTANTS LTD→ 12269318 · est 2019 · no financials extracted	—	—	—	—	6y	—	—
ABSOLUTE TRANSPORT CONSULTANCY LTD→ 16685558 · est 2025 · no financials extracted	—	—	—	—	—	—	—

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2012-02-24

Jurisdictionengland-wales

Primary SIC72110 — Research and experimental development on biotechnology

Registered office

10 Station Yard

Tiddington

Thame

OX9 2FG

England

Filing status

Accounts

Next due: 2027-12-31

Last made up to: 2026-03-31

Confirmation statement

Next due: 2027-03-10

Last: 2026-02-24

Officers (2 active · 0 resigned)

BANYARD, Alan Frederick→

director · ~71y · appointed 2012-02-24

View their other companies + combined net worth →

Active

BANYARD, Petula Nancy→

director · ~70y · appointed 2012-02-24

View their other companies + combined net worth →

Active

Click a director name to see their full track record across all companies.